Skip to content

13F-HR filed by B Group, Inc.

B Group, Inc. filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 13:19:16 UTC, with 19 holding rows worth $162,133,739.

Accession
0001420506-26-002733
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

13F report for Q3 2026

A holdings report, 19 entries on the cover page, a total value of $162,133,739 stated on the cover page (in dollars after the unit check, H1), rows summing to $162,133,739 with VALUE read as dollars as filed, 13F file number 028-25141. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ADMA BIOLOGICS INC000899104COM3,262,542$32,723,296dollars as filed
FAETH THERAPEUTICS INC81728A207COM NEW610,169$18,146,426dollars as filed
PALISADE BIO INC696389402COMMON STOCK11,414,285$15,409,285dollars as filed
NRX PHARMACEUTICALS INC629444209COM NEW4,277,200$12,489,424dollars as filed
ZAI LAB LTD ADR98887Q104ADR450,646$11,870,016dollars as filed
PRAXIS PRECISION MEDICINES I74006W207COM NEW33,237$9,679,612dollars as filed
SIGHT SCIENCES INC82657M105COMMON STOCK970,000$9,079,200dollars as filed
TAYSHA GENE THERAPIES INC877619106COMMON STOCK1,800,556$8,768,708dollars as filed
IOVANCE BIOTHERAPEUTICS INC462260100COM425,000$6,298,500dollars as filed
STRUCTURE THERAPEUTICS INC COMP86366E106EQUITY180,000$5,628,600dollars as filed
SPYRE THERAPEUTICS INC00773J202COM NEW62,500$5,564,375dollars as filed
CELLECTIS ADS15117K103COM3,281,501$4,955,067dollars as filed
AURA BIOSCIENCES INC05153U107COMMON STOCK764,243$4,799,446dollars as filed
BRIGHT MINDS BIOSCIENCES INC10919W405COMMON STOCK95,000$4,732,900dollars as filed
ORUKA THERAPEUTICS INC COM687604108Stock55,000$4,580,950dollars as filed
ASSEMBLY BIOSCIENCES INC045396207COMMON STOCK175,706$4,127,334dollars as filed
ULTRAGENYX PHARMACEUTICAL IN90400D108COM135,000$2,029,050dollars as filed
FOGHORN THERAPEUTICS INC344174107COMMON STOCK200,000$714,000dollars as filed
Q32 BIO INC746964105Common Stock65,000$537,550dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001420506-26-002733this filing2026-11-16